Global Ophthalmic Diagnostic Devices Market

Ophthalmic Diagnostic Devices Market Size, Share, Growth Analysis, By Product (Fundus Cameras, Retinal Ultrasound Imaging Systems), By End User (Hospitals, Clinics), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2725 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 64 | Figures: 77

Ophthalmic Diagnostic Devices Market News

  • In March 2023, Alcon announced the launch of its new LenSx laser system for cataract surgery.
  • In February 2023, Johnson & Johnson Vision launched its new Acuvue Oasys with Transitions lenses, which are designed to automatically adjust to changing light conditions.
  • In January 2023, Carl Zeiss Meditec announced the launch of its new VisuMax femtosecond laser system for cataract surgery.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Ophthalmic Diagnostic Devices Market size was valued at USD 2.71 Billion in 2023 and is poised to grow from USD 2.88 Billion in 2024 to USD 4.67 Billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).

The competitive landscape of the ophthalmic diagnostic devices market is characterized by the presence of several key players who offer a wide range of technologically advanced products. These companies strive to develop innovative devices that provide accurate and efficient diagnosis, enabling better patient care. 'Carl Zeiss Meditec AG ', 'Topcon Corporation ', 'NIDEK Co., Ltd. ', 'Canon Inc. ', 'Haag-Streit AG ', 'Optovue, Inc. ', 'Bausch + Lomb ', 'Essilor Instruments ', 'Kowa Company, Ltd. ', 'AMETEK, Inc. ', 'Swiss Biotech  ', 'Avisi Technologies, LLC  ', 'Azura Ophthalmics  '

The global healthcare expenditure has been steadily increasing, driven by economic growth, expanding health insurance coverage, and government initiatives to improve healthcare infrastructure. This rise in healthcare spending has positively impacted the ophthalmic diagnostic devices market as healthcare facilities and professionals invest in advanced diagnostic equipment to deliver high-quality eye care services.

Ophthalmic diagnostic devices generate a vast amount of data, including imaging data, patient records, and treatment outcomes. The integration of big data analytics allows for efficient storage, analysis, and interpretation of this data, enabling better decision-making, personalized treatment plans, and the development of predictive models for disease progression.

It is expected that North America would hold the largest share of this market, with revenue of USD 907.2 million in 2022. The market for ophthalmic diagnostic devices in the area is anticipated to be driven by high adoption of cutting-edge ophthalmology diagnostic tools, growing awareness of ocular ailments, and rising prevalence of refractive error disorders. Approximately 35.1% of Americans under 50 are myopic, according to a Journal of Current Ophthalmology report. In the upcoming years, it is predicted that the market in this region will grow because of the increased frequency of cataract and myopia.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Ophthalmic Diagnostic Devices Market

Report ID: SQMIG35A2725

$5,300
BUY NOW GET FREE SAMPLE